Skip to content

Clinical trial on prognostic factors of lymphoma with fever

Clinical trial on prognostic factors of lymphoma with fever

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100052451
Enrollment
Unknown
Registered
2021-10-26
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lymphoma

Interventions

Febrile lymphoma group vs non-febrile lymphoma group:no

Sponsors

Huadong Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The definition and diagnosis of lymphoma should comply with the WHO classification criteria for lymphatic hematopoietic tumors in 2016. All patients were confirmed by histopathology.

Exclusion criteria

Exclusion criteria: Recurrent lymphoma.

Design outcomes

Primary

MeasureTime frame
Progression-Free Survival;

Countries

China

Contacts

Public ContactShen Lin

Huadong Hospital, Fudan University

shenlin1979@hotmail.com+86 13917415625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026